Across TCGA pan-cancer cohorts, CYCSP6 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated CYCSP6 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher CYCSP6 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CYCSP6 expression acts as an unfavorable survival marker.

ESCA are the cancer types where CYCSP6 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Median	III,IV	0.100	0.442	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: CYCSP6 tumor-vs-normal RNA expression · all CYCSP6 data types